Markus J. Cappel, Chief Business Officer & Treasurer at ChemoCentryx, Inc. (CCXI), sold 2,709 shares at $13.00 ($35K) on 2018-05-21, disclosed to the SEC on 2018-05-23.
Scheduled sale ($35k) by Chief Business Officer & Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CCXI | SELL | 2021-02-11 | $49K | — | Filing → |
| CCXI | SELL | 2021-02-08 | $1.2M | — | Filing → |
| CCXI | SELL | 2021-01-27 | $184K | — | Filing → |